Investigators sought to determine the association between maternal vaccination and infant mortality.
As a result of activating the inflammatory-immune system, pneumonia may trigger cardiovascular complications.
Researchers found the strongest link between prescription opioid use and the risk for invasive pneumococcal disease was present in individuals using long-acting, high-dose, or highly potent formulations.
Influenza A viruses have predominated the 2017 to 2018 season with a vaccine effectiveness between 25% and 67%.
Airborne influenza viruses may be safely and effectively eradicated with continuous low doses of far ultraviolet C light.
Long-acting, high-potency, and high-dose opioids were associated with an increased risk for invasive pneumococcal disease.
The recommended childhood and adolescent immunization schedule for the United States has been issued for 2018.
Invasive mechanical ventilation in patients with severe community-acquired pneumonia appeared to increase their mortality risk.
Nasopharyngeal samples collected from young children with acute otitis media were analyzed for S pneumoniae, H influenzae, and Moraxella catarrhalis and compared before and after PCV13 introduction.
Patient, practice, and provider characteristics are associated with inappropriate antimicrobial prescribing in the outpatient setting.
The FDA approved the supplemental New Drug Application for Avycaz to treat adults with hospital-acquired or ventilator-associated bacterial pneumonia.
The preoperative physiotherapy intervention cut the incidence of postoperative pulmonary complications by 50%.
Procalcitonin may decrease mortality rates in patients with acute respiratory infections, including pneumonia.
Patients who received provider-ordered influenza testing were more likely to be younger and present with fever and "influenza-like illness."
Influenza increased the risk for acute myocardial infarction within 1 year before and 1 year after the infection.
Short-term incidence of leukemia, lymphoma, and brain cancer may be higher in children who were hospitalized with pneumonia.
Patient reminder and recall systems seem to be effective for improving receipt of immunizations.
For febrile infants, human rhinovirus is common, and detection does not alter risk of concomitant urinary tract infection or invasive bacterial infection.
Mortality from severe pneumonia may be significantly reduced with corticosteroids.
A gas-capillary column ion mobility spectrometer may be a feasible and noninvasive tool for clinicians to diagnose respiratory tract infections in hospitalized patients.